Spots Global Cancer Trial Database for Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer
Official Title: Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer
Study ID: NCT00590109
Conditions
Study Description
Brief Summary: The purpose of this project is to further characterize inherited predisposition to breast cancer mediated by specific BRCA alleles (BRACA1 185delAG and 5382insC; BRCA2 6174delT) among Jewish women.
Detailed Description:
Eligibility
Minimum Age: 19 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Locations
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact Details
Name: Kenneth Offit, MD
Affiliation: Memorial Sloan Kettering Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
